{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:33:32Z","timestamp":1787852012467,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.01.179","type":"journal-article","created":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T00:16:49Z","timestamp":1488673009000},"page":"617-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Protective effect of Aster tataricus extract on retinal damage on the virtue of its antioxidant and anti-inflammatory effect in diabetic rat"],"prefix":"10.1016","volume":"89","author":[{"given":"Hao","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.179_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1758-5996-5-57","article-title":"Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study","volume":"5","author":"Litwak","year":"2003","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2017.01.179_bib0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0974-9233.92118","article-title":"Role of inflammation in the pathogenesis of diabetic retinopathy","volume":"19","author":"El-Asrar","year":"2012","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2017.01.179_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","article-title":"Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies","volume":"148","author":"Rani","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2017.01.179_bib0020","first-page":"1","article-title":"Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies","volume":"21","author":"Tripathi","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.biopha.2017.01.179_bib0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/02713683.2012.661114","article-title":"Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy","volume":"37","author":"Zhou","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2017.01.179_bib0030","first-page":"105","article-title":"Protective factors in diabetic retinopathy: focus on blood-retinal barrier","volume":"18","author":"Zhang","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.biopha.2017.01.179_bib0035","doi-asserted-by":"crossref","first-page":"279393","DOI":"10.1155\/2015\/279393","article-title":"Elevated serum levels of soluble TNF receptors and adhesion molecules are associated with diabetic retinopathy in patients with Type-1 diabetes","volume":"2015","author":"Sharma","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2017.01.179_bib0040","first-page":"635","article-title":"Medical management of diabetic retinopathy: an overview","volume":"15","author":"Malek","year":"2012","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.biopha.2017.01.179_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/aos.12249","article-title":"Diabetic vitrectomy in a large type 1 diabetes patient population: long-term incidence and risk factors","volume":"92","author":"Ostri","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2017.01.179_bib0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","article-title":"Plant polyphenols as dietary antioxidants in human health and disease","volume":"2","author":"Pandey","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.01.179_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0031-9422(00)90528-4","article-title":"Terpenoid glycosides from the roots of Aster tataricus","volume":"35","author":"Dongliang","year":"1993","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2017.01.179_bib0060","series-title":"Encyclopaedia of Herbs and Their Uses","author":"Bown","year":"1995"},{"key":"10.1016\/j.biopha.2017.01.179_bib0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jep.2015.02.036","article-title":"Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricus","volume":"164","author":"Yu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.01.179_bib0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/np50119a001","article-title":"Studies on the inhibitory effects of caffeoylquinic acids on monocyte migration and superoxide ion production","volume":"58","author":"Peluso","year":"1995","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.01.179_bib0075","series-title":"Medicinal Plants of China","author":"Duke","year":"1985"},{"key":"10.1016\/j.biopha.2017.01.179_bib0080","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1021\/jf202028y","article-title":"Two new antioxidant malonated caffeoylquinic acid isomers in fruits of wild eggplant relatives","volume":"59","author":"Ma","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.01.179_bib0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1532-0456(03)00170-4","article-title":"Antioxidant activity of compounds from the medicinal herb Aster tataricus","volume":"136","author":"Ng","year":"2003","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.179_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2251-6581-13-8","article-title":"Changes in the pharmacokinetic of sildenafil citrate in rats with Streptozotocin-induced diabetic nephropathy","volume":"13","author":"Tripathi","year":"2014","journal-title":"J. Diabetes Metabol. Disorders"},{"key":"10.1016\/j.biopha.2017.01.179_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/jbcpp-2015-0035","article-title":"Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in STZ-induced diabetic rats","volume":"27","author":"Tripathi","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.179_bib0100","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3390\/nu8010017","article-title":"Polyphenols and glycemic control","volume":"8","author":"Kim","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2017.01.179_bib0105","first-page":"598","article-title":"Free radicals, antioxidants, and human disease: where are we now?","volume":"119","author":"Halliwell","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2017.01.179_bib0110","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3892\/mmr.2015.3613","article-title":"Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats","volume":"12","author":"Kim","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2017.01.179_bib0115","doi-asserted-by":"crossref","first-page":"e33864","DOI":"10.1371\/journal.pone.0033864","article-title":"Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats","volume":"7","author":"Pouliot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.01.179_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: A key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Investig."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217302706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217302706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:11:33Z","timestamp":1760094693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217302706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":24,"alternative-id":["S0753332217302706"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.179","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of Aster tataricus extract on retinal damage on the virtue of its antioxidant and anti-inflammatory effect in diabetic rat","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}